| http://www.w3.org/ns/prov#value | - The test substances are active in this test at doses from 0.1 to 5 mg/kg, when GH level in the blood serum is determined by radio-immunoassay 1 and 2 hours after oral administration.The compounds of the invention are accordingly indicated for use in the treatment of disorders with an aetiology comprising or associated with excess GH-secretion, e.g. in the treatment of acromegaly as well as in the
|
